Biophytis

Quick facts

Phase 2 pipeline

• BIO101 · Neurology
  BIO101 is a small molecule targeting the SARM1 protein to prevent mitochondrial dysfunction.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Biophytis portfolio CI brief
• Biophytis pipeline updates RSS